Connect to other sites within the UBM Medica Network
Serum Cholesterol, Meds Don't Explain Bipolar's High Suicide Risk
New research exonerates cholesterol and psychotropic medications as contributing factors in the increased suicide risk among bipolar patients. Lithium seems even to reduce the risk of suicide.
Some Drugs Increase Risk of New-Onset Diabetes
Diuretics and statins appear to increase the risk of new-onset diabetes among those with impaired glucose tolerance and other cardiovascular risk factors.
Genetic Factors Modify HDL Cholesterol and Lipid Levels in Diabetes
A study has identified genetic variants that modify lipid responses to lifestyle changes in above-normal-weight people with diabetes.
HDL and ApoA-1 Levels Reflect Lower Cardiovascular Risk for Statin Users
ApoA-1 is suggested as the best target for reducing cardiovascular risk in patients on statins. Other research suggests that entirely different measures of lipid-related risk may be needed.
Lipid Levels, Blood Pressure Improving Nationwide
Increases in use of antihypertensives and lipid-modifying drugs show good results in a national survey.
FGFs Emerging as Cardiovascular Biomarkers
Serum levels of fibroblast growth factor 19 and 21 appear to correlate with atherosclerosis. But they differ in their relation to lipid profiles.
Niacin Supplementation Does Not Boost Statins' Effects on HDL
A small randomized trial has confirmed previous evidence that adding niacin to a statin in an attempt to raise high-density lipoprotein (HDL) cholesterol levels does not improve cardiovascular outcomes.
By clicking Accept, you agree to become a member of the UBM Medica Community.